Active substance
Results for the substance obinutuzumab
1 result
About this active substance
Obinutuzumab is a monoclonal antibody used for the treatment of certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia. It works by binding to the CD20 protein on the surface of B lymphocytes, leading to their destruction.
The medication is administered intravenously, following a specific schedule determined by the doctor. It is important to monitor side effects and undergo regular tests to assess the effectiveness of the treatment.
Side effects may include fever, nausea, fatigue, infections, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of obinutuzumab.
The medication is administered intravenously, following a specific schedule determined by the doctor. It is important to monitor side effects and undergo regular tests to assess the effectiveness of the treatment.
Side effects may include fever, nausea, fatigue, infections, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of obinutuzumab.